John B. Sharefkin

1.7k total citations
39 papers, 1.3k citations indexed

About

John B. Sharefkin is a scholar working on Surgery, Molecular Biology and Biomaterials. According to data from OpenAlex, John B. Sharefkin has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 11 papers in Molecular Biology and 9 papers in Biomaterials. Recurrent topics in John B. Sharefkin's work include Electrospun Nanofibers in Biomedical Applications (9 papers), Tissue Engineering and Regenerative Medicine (6 papers) and Infectious Aortic and Vascular Conditions (4 papers). John B. Sharefkin is often cited by papers focused on Electrospun Nanofibers in Biomedical Applications (9 papers), Tissue Engineering and Regenerative Medicine (6 papers) and Infectious Aortic and Vascular Conditions (4 papers). John B. Sharefkin collaborates with scholars based in United States, Switzerland and Japan. John B. Sharefkin's co-authors include Carl W. Dieffenbach, Scott L. Diamond, Larry V. McIntire, Todd M. Lowe, Shi Qi Yang, Karen F. Frasier-Scott, S. G. Eskin, Suzanne G. Eskin, Norman M. Rich and J. Hay and has published in prestigious journals such as JAMA, Nucleic Acids Research and Circulation.

In The Last Decade

John B. Sharefkin

38 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John B. Sharefkin United States 19 423 387 235 234 211 39 1.3k
Jean‐Luc Rummens Belgium 21 366 0.9× 389 1.0× 158 0.7× 77 0.3× 48 0.2× 46 1.9k
J. M. Papadimitriou Australia 22 234 0.6× 624 1.6× 31 0.1× 241 1.0× 312 1.5× 86 1.6k
Eleuterio Lombardo Spain 24 603 1.4× 771 2.0× 109 0.5× 256 1.1× 222 1.1× 47 2.6k
Huaiqing Chen China 20 202 0.5× 437 1.1× 100 0.4× 62 0.3× 76 0.4× 100 1.1k
A P Dalmasso United States 16 652 1.5× 226 0.6× 67 0.3× 180 0.8× 83 0.4× 30 1.9k
Wolfgang Sipos Austria 26 150 0.4× 787 2.0× 88 0.4× 50 0.2× 184 0.9× 77 1.8k
Daniela Montagna Italy 32 478 1.1× 646 1.7× 87 0.4× 216 0.9× 189 0.9× 109 4.0k
E Bastounis Greece 21 428 1.0× 321 0.8× 37 0.2× 385 1.6× 47 0.2× 109 1.4k
Marjorie Fowler United States 23 360 0.9× 212 0.5× 19 0.1× 341 1.5× 83 0.4× 68 1.4k
Geoffrey Y. Akita United States 19 210 0.5× 778 2.0× 64 0.3× 132 0.6× 304 1.4× 27 1.7k

Countries citing papers authored by John B. Sharefkin

Since Specialization
Citations

This map shows the geographic impact of John B. Sharefkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John B. Sharefkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John B. Sharefkin more than expected).

Fields of papers citing papers by John B. Sharefkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John B. Sharefkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John B. Sharefkin. The network helps show where John B. Sharefkin may publish in the future.

Co-authorship network of co-authors of John B. Sharefkin

This figure shows the co-authorship network connecting the top 25 collaborators of John B. Sharefkin. A scholar is included among the top collaborators of John B. Sharefkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John B. Sharefkin. John B. Sharefkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamaguchi, Masahiko, Scott L. Diamond, Hiroyuki Watanabe, et al.. (1993). Heparin and dibutyryl cAMP modulate gene expression in stimulated human saphenous vein smooth muscle cells. In Vitro Cellular & Developmental Biology - Animal. 29(11). 867–872. 4 indexed citations
5.
Sharefkin, John B., et al.. (1992). Adventitial cystic disease of the femoral vein: A case report and review of the literature. Journal of Vascular Surgery. 15(1). 214–217. 3 indexed citations
6.
Tesh, Vernon L., et al.. (1991). Evaluation of the Role of Shiga and Shiga-like Toxins in Mediating Direct Damage to Human Vascular Endothelial Cells. The Journal of Infectious Diseases. 164(2). 344–352. 106 indexed citations
7.
Yamaguchi, Masahiko, et al.. (1991). Effects of aspirin, dipyridamole, and dibutyryl cyclic adenosine monophosphate on platelet-derived growth factor A chain mRNA levels in human saphenous vein endothelial cells and smooth muscle cells.. PubMed. 110(2). 377–83; discussion 383. 6 indexed citations
8.
Brown, James M., Alden H. Harken, & John B. Sharefkin. (1990). Recombinant DNA and Surgery. Annals of Surgery. 212(2). 178–186. 10 indexed citations
9.
Diamond, Scott L., John B. Sharefkin, Carl W. Dieffenbach, et al.. (1990). Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress. Journal of Cellular Physiology. 143(2). 364–371. 218 indexed citations
10.
Lowe, Todd M., John B. Sharefkin, Shi Qi Yang, & Carl W. Dieffenbach. (1990). A computer program for selection of oligonucleotide primers for polymerase chain reactions. Nucleic Acids Research. 18(7). 1757–1761. 162 indexed citations
11.
Zilla, Peter, et al.. (1989). Reduced reproductive capacity of freshly harvested endothelial cells in smokers: A possible shortcoming in the success of seeding?. Journal of Vascular Surgery. 10(2). 143–148. 19 indexed citations
12.
Limanni, Alex, Timothy P. Fleming, Rodolfo Molina, et al.. (1988). Expression of genes for platelet-derived growth factor in adult human venous endothelium. Journal of Vascular Surgery. 7(1). 10–20. 1 indexed citations
13.
Sharefkin, John B., Harold E. Van Wart, David F. Cruess, Robert A. Albus, & Elliot M. Levine. (1986). Adult human endothelial cell enzymatic harvesting. Journal of Vascular Surgery. 4(6). 567–577. 8 indexed citations
14.
Sharefkin, John B., et al.. (1986). Migration of adult human vascular endothelial cells: effect of extracellular matrix proteins.. PubMed. 100(2). 384–91. 29 indexed citations
15.
Sharefkin, John B., et al.. (1986). Use of tritiated thymidine as a marker to compare the effects of matrix proteins on adult human vascular endothelial cell attachment: implications for seeding of vascular prostheses.. PubMed. 100(5). 884–92. 23 indexed citations
16.
Watkins, Michael T., John B. Sharefkin, Rostik Zajtchuk, et al.. (1984). Adult human saphenous vein endothelial cells: Assessment of their reproductive capacity for use in endothelial seeding of vascular prostheses. Journal of Surgical Research. 36(6). 588–596. 81 indexed citations
17.
Clagett, G, W. E. Burkel, John B. Sharefkin, et al.. (1984). Platelet reactivity in vivo in dogs with arterial prostheses seeded with endothelial cells.. Circulation. 69(3). 632–639. 41 indexed citations
18.
Sharefkin, John B., et al.. (1983). Endothelial cell labeling with indium‐111‐oxine as a marker of cell attachment to bioprosthetic surfaces. Journal of Biomedical Materials Research. 17(2). 345–357. 58 indexed citations
19.
Sharefkin, John B., et al.. (1982). Technical considerations in the study of indium-111-oxine labelled platelet survival patterns in dogs.. PubMed. 32(2). 183–6. 2 indexed citations
20.
Sharefkin, John B.. (1972). Pulmonary Arterial Pressure as a Guide to the Hemodynamic Status of Surgical Patients. Archives of Surgery. 105(5). 699–699. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026